Allan Wood appointed Non-Executive Director of Liberata

Board signing brings high growth experience and technology experience

Liberata, a provider of services to government, announced today that Allan Wood has been appointed as Non-Executive Director. Allan’s appointment strengthens Liberata’s governance structure, whist also providing the board with valued expertise and experience gained through senior positions and chairmanships in a range of high growth companies.

“As government seeks to reform and modernise, it needs partners it can rely on to help it improve services, manage and run them on its behalf, and increasingly digitalise and automate them. Having been trusted by the public sector for more than 40 years to deliver, run and automate complex services, this creates a great opportunity for Liberata,” said Charlie Bruin, Liberata CEO. “Allan already knows our business well, and his experience of high-growth companies will be very valuable as we look to broaden and deepen our customer engagements.”

Allan also serves as Chairman of Venn Life Sciences, IT Lab and is Non-Executive Director at Oxehealth, a technology developer that monitors vital signs that was spun out of The University of Oxford. Allan previously served as Chairman of Healthcare Homes, a provider of residential and domiciliary care homes; and Harmoni (now Care UK), a primary healthcare provider.

“I’m delighted to join the Liberata board. It’s a fantastic company, with great leadership and values. It is clear from its long-standing client partnerships that it delivers positive outcomes where others can’t, as well as ensuring it is positively contributing to the local communities in which it operates,” said Allan Wood, Non-Executive Director, Liberata. “What really stands out about Liberata is that its people genuinely understand the complexities of government processes, while having the innovative thinking needed to automate and digitalise services.”

See how Liberata can help your organisation.

Book A Demo

Newsletter Sign Up

Sign up for the latest news and insights from Liberata.

Sign Up Today
Connect with us:

Back to top